EARS

Auris Medical Stock Price

3.14
0.13 (4.32%)
Upgrade to Real-Time
Afterhours (Closed)
3.14

Low
0.7255

52 Week Range

High
6.575

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Auris Medical Holding AG EARS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.13 4.32% 3.14 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.16 3.03 3.19 3.11 3.01
Bid Price Ask Price Spread News
3.05 3.09 0.04 - 2
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,732 629,354 $ 3.12 $ 1,964,801 6,544,964 0.7255 - 6.575
Last Trade Time Type Quantity Stock Price Currency
19:52:42 53 $ 3.09 USD

Auris Medical Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 22.26M 7.09M 1.56M $ 197.59k $ - -14.64 5.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Auris Medical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EARS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.05414.342.883.339,076,9070.08592.81%
1 Month3.554.342.763.282,913,175-0.41-11.55%
3 Months4.256.252.704.055,491,589-1.11-26.12%
6 Months0.836.5750.82774.396,071,9002.31278.31%
1 Year0.9246.5750.72553.823,551,8642.22239.83%
3 Years35.2039.400.658.392,102,824-32.06-91.08%
5 Years63.00109.000.6510.091,493,904-59.86-95.02%

Auris Medical Description

Auris Medical Holding Ltd is a clinical-stage biopharmaceutical company. The company develops therapeutics that address important unmet medical needs in neurotology, rhinology, allergy, and CNS disorders. It has two projects in clinical development: Keyzilen for the treatment of acute inner ear tinnitus and Sonsuvi for the treatment of acute inner ear hearing loss. Its other product candidates are AM-125, AM-201, and AM-301.


Your Recent History
NASDAQ
EARS
Auris Medi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.